Anticoagulation Control in Older Atrial Fibrillation Patients Receiving Vitamin K Antagonist Therapy for Stroke Prevention
Introduction. Efficacy and safety of vitamin K antagonists (VKAs) among atrial fibrillation (AF) patients are enhanced when the International Normalised Ratio (INR) is 2.0-3.0. Anticoagulation control among older patients is perceived to be lower and contributes to poorer initiation and uptake. Obje...
| Published in: | International Journal of Clinical Practice |
|---|---|
| Main Author: | |
| Format: | Article |
| Language: | English |
| Published: |
Wiley-Hindawi
2022
|
| Online Access: | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85131703299&doi=10.1155%2f2022%2f5951262&partnerID=40&md5=e7e87ddffe644ceb964609ad6eecb442 |